SCHEMBL3499404

SCHEMBL3499404

CCOC(=O)[C@H](CCSC)NC(=O)c1oc2cc(-c3ccc(Cl)cc3)ccc2c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPID Q08752 1/20 0.41
FPR1 P21462 5/20 0.41
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
MCL1 Q07820 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
FNTA P49354 2/20 0.39
FNTB P49356 2/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3499402 1.00 PPID (0.41) PPIDFPR1TAS1R3TAS1R1MCL1
SCHEMBL3498404 0.90 ALDH1A1 (0.49) FPR1MCL1FNTAFNTBALDH1A1
SCHEMBL3498408 0.90 ALDH1A1 (0.49) FPR1MCL1FNTAFNTBALDH1A1
SCHEMBL3500038 0.89 PPID (0.38) PPIDTAS1R3TAS1R1L3MBTL1FNTA
SCHEMBL3500039 0.89 PPID (0.38) PPIDTAS1R3TAS1R1L3MBTL1FNTA
SCHEMBL3501302 0.79 ALDH1A1 (0.44) FNTAFNTBALDH1A1GAATSHR
SCHEMBL3501304 0.79 ALDH1A1 (0.44) FNTAFNTBALDH1A1GAATSHR
SCHEMBL3504494 0.77 CAPN1 (0.49) ALDH1A1KDM4E
SCHEMBL3504496 0.77 CAPN1 (0.49) ALDH1A1KDM4E
SCHEMBL3499722 0.76 HIF1A (0.55) MCL1L3MBTL1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
EP-1849465-A1 AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR Takeda Pharmaceutical Company Limited (JP) 2007-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function GPR34, GPR4, GPR6 PPID 4643/4885FPR1 400/4885TAS1R3 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.